cbdMD (YCBD) EPS (Basic) Growth (3y) (2019 - 2025)
cbdMD (YCBD) EPS (Basic) Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 53.26% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.07% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.72% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -47.34% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 65.02% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -19.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -78.78% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 262.79% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -100.00% |
| 10 | cbdMD | 3,905.91 | -3.38 Mn | 3.00 Mn | 77.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.89% |
| Sep 30, 2025 | -672.46% |
| Jun 30, 2025 | 27.45% |
| Mar 31, 2025 | -166.84% |
| Dec 31, 2024 | -70.34% |
| Sep 30, 2024 | -1,288.30% |
| Jun 30, 2024 | -665.46% |
| Mar 31, 2024 | -256.13% |
| Dec 31, 2023 | -54.98% |
| Sep 30, 2023 | -1,154.26% |
| Jun 30, 2023 | -86.09% |
| Mar 31, 2023 | -84.14% |
| Dec 31, 2022 | -115.76% |
| Sep 30, 2022 | -29.04% |
| Jun 30, 2022 | 22.02% |
| Mar 31, 2022 | 68.27% |
| Dec 31, 2021 | -18.56% |
| Sep 30, 2021 | 13.99% |
| Jun 30, 2021 | -12.64% |
| Mar 31, 2021 | -50.54% |